medigraphic.com
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

2017, Number 6

<< Back Next >>

Rev Invest Clin 2017; 69 (6)

Two-hundred Years Later: Is Parkinson’s Disease a Single Defined Entity?

Rodríguez-Violante M, Cervantes-Arriaga A, Fahn S, Tolosa E

Language: English
References: 35
Page: 308-313
PDF size: 89.40 Kb.


ABSTRACT

An Essay on the Shaking Palsy, by James Parkinson, was published in 1817. Later, Jean-Martin Charcot better described some of the motor features of the disease and named the condition as “La Maladie de Parkinson.” As understanding about the disease progressed, aided by both clinical expertise and technological developments, the definition of what is Parkinson’s disease has evolved. Motor phenotype, non-motor symptoms, monogenic mutations, genetic risk factors, disease subtyping, and data-driven clusters, among other concepts, have given rise to the hypothesis that Parkinson’s disease may be not one well-defined entity but several different diseases encompassed as a levodopa-responsive Parkinsonism. This review present and discusses several of these factors and how they may support or not the notion of Parkinson’s being one or more diseases. In summary, current evidence appears to be insufficient at this moment to clarify this issue. Parkinson’s disease will continue to be an evolving concept over the years to come.


REFERENCES

  1. Lewy FH. Paralysis agitans: Pathologische anatomie. Handbuch der Neurologie. Vol. 3. Berlin: Springer; 1912. p. 920-33.

  2. Montagu KA. Catechol compounds in rat tissues and in brains of different animals. Nature. 1957;180:244-5.

  3. Carlsson A, Lindqvist M, Magnusson T. 3, 4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists. Nature. 1957;180:1200.

  4. Polymeropoulos MH, Lavedan C, Leroy E, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson’s disease. Science. 1997;276:2045-7.

  5. Jakes R, Spillantini MG, Goedert M. Identification of two distinct synclines from human brain. FEBS Lett. 1994;345:27-32.

  6. Marsden CD. Parkinson’s disease. J Neurol Neurosurg Psychiatry. 1994;57:672-81.

  7. Kalia LV, Lang AE. Parkinson’s disease. Lancet. 2015;386: 896-912.

  8. Berg D, Postuma RB, Bloem B, et al. Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson’s disease. Mov Disord. 2014;29:454-62.

  9. Kell DB, Oliver SG. Here is the evidence, now what is the hypothesis? The complementary roles of inductive and hypothesis- driven science in the post-genomic era. Bioessays. 2004; 26:99-105.

  10. Marras C, Lang A. Parkinson’s disease subtypes: Lost in translation? J Neurol Neurosurg Psychiatry. 2013;84:409-15.

  11. Marras C. Subtypes of Parkinson’s disease: State of the field and future directions. Curr Opin Neurol. 2015;28:382-6.

  12. van Rooden SM, Heiser WJ, Kok JN, Verbaan D, van Hilten JJ, Marinus J. The identification of Parkinson’s disease subtypes using cluster analysis: A systematic review. Mov Disord. 2010; 25:969-78.

  13. Zetusky WJ, Jankovic J, Pirozzolo FJ. The heterogeneity of Parkinson’s disease: Clinical and prognostic implications. Neurology. 1985;35:522-6.

  14. Jankovic J, McDermott M, Carter J, et al. Variable expression of Parkinson’s disease: A base-line analysis of the DATATOP cohort. The Parkinson study group. Neurology. 1990;40: 1529-34.

  15. van der Heeden JF, Marinus J, Martinez-Martin P, Rodriguez- Blazquez C, Geraedts VJ, van Hilten JJ. Postural instability and gait are associated with severity and prognosis of Parkinson disease. Neurology. 2016;86:2243-50.

  16. Burn DJ, Rowan EN, Allan LM, Molloy S, O Brien JT, McKeith IG. Motor subtype and cognitive decline in Parkinson’s disease, Parkinson’s disease with dementia, and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry. 2006;77:585-9.

  17. Thenganatt MA, Jankovic J. Parkinson disease subtypes. JAMA Neurol. 2014;71:499-504.

  18. Nagae LM, Honce JM, Tanabe J, Shelton E, Sillau SH, Berman BD. Microstructural changes within the basal ganglia differ between Parkinson disease subtypes. Front Neuroanat. 2016;10:17.

  19. Vervoort G, Alaerts K, Bengevoord A, et al. Functional connectivity alterations in the motor and fronto-parietal network relate to behavioral heterogeneity in Parkinson’s disease. Parkinsonism Relat Disord. 2016;24:48-55.

  20. Rajput AH, Voll A, Rajput ML, Robinson CA, Rajput A. Course in Parkinson disease subtypes: A 39-year clinic pathologic study. Neurology. 2009;73:206-12.

  21. Stebbins GT, Goetz CG, Burn DJ, Jankovic J, Khoo TK, Tilley BC. How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society-unified Parkinson’s disease rating scale: Comparison with the unified Parkinson’s disease rating scale. Mov Disord. 2013;28: 668-70.

  22. Simuni T, Caspell-Garcia C, Coffey C, et al. How stable are Parkinson’s disease subtypes in de novo patients: Analysis of the PPMI cohort? Parkinsonism Relat Disord. 2016;28:62-7.

  23. Alves G, Larsen JP, Emre M, Wentzel-Larsen T, Aarsland D. Changes in motor subtype and risk for incident dementia in Parkinson’s disease. Mov Disord. 2006;21:1123-30.

  24. Nutt JG. Motor subtype in Parkinson’s disease: Different disorders or different stages of disease? Mov Disord. 2016; 31:957-61.

  25. Sauerbier A, Jenner P, Todorova A, Chaudhuri KR. Non motor subtypes and Parkinson’s disease. Parkinsonism Relat Disord. 2016;22 Suppl 1:S41-6.

  26. van Rooden SM, Visser M, Verbaan D, Marinus J, van Hilten JJ. Patterns of motor and non-motor features in Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2009;80:846-50.

  27. Erro R, Picillo M, Vitale C, et al. Clinical clusters and dopaminergic dysfunction in de-novo Parkinson disease. Parkinsonism Relat Disord. 2016;28:137-40.

  28. van Rooden SM, Colas F, Martínez-Martín P, et al. Clinical subtypes of Parkinson’s disease. Mov Disord. 2011;26:51-8.

  29. Fereshtehnejad SM, Romenets SR, Anang JB, Latreille V, Gagnon JF, Postuma RB. New clinical subtypes of Parkinson disease and their longitudinal progression: A prospective cohort comparison with other phenotypes. JAMA Neurol. 2015;72:863-73.

  30. Marras C, Chaudhuri KR. Nonmotor features of Parkinson’s disease subtypes. Mov Disord. 2016;31:1095-2.

  31. Lawton M, Baig F, Rolinski M, et al. Parkinson’s disease subtypes in the oxford Parkinson disease centre (OPDC) discovery cohort. J Parkinsons Dis 2015;5:269-79.

  32. Takahashi H, Ohama E, Suzuki S, et al. Familial juvenile parkinsonism: Clinical and pathologic study in a family. Neurology. 1994;44:437-1.

  33. Zimprich A, Biskup S, Leitner P, et al. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron. 2004;44:601-7.

  34. Kumaran R, Cookson MR. Pathways to Parkinsonism Redux: Convergent path biological mechanisms in genetics of Parkinson’s disease. Hum Mol Genet. 2015;24:R32-44.

  35. Lin MK, Farrer MJ. Genetics and genomics of Parkinson’s disease. Genome Med. 2014;6:48.




2020     |     www.medigraphic.com